Skip to main content

Born to Play?

At least two companies have begun selling tests that claim to help determine if a child is genetically programmed to play a certain sport, says The Washington Post's Rob Stein. The companies say their tests can set children on a course to playing a sport for which they have "innate skills" and could get scholarships, Stein adds. But critics are calling these tests "questionable" and say that no DNA kit can tell a parent whether their children's genes will influence their athletic prowess. FDA, which is already trying to figure out how to regulate all of the DTC genetic tests flooding the market, has sent a letter to at least one of the companies selling a sports test, demanding an explanation for the company's marketing of the test without FDA authorization, Stein says. "I think this company is a good advertisement for the need for more regulation of genomic testing," Stanford University bioethicist Hank Greely tells Stein.

Our sister publication GenomeWeb Daily News has more on the letters sent by FDA.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.